Postremission therapy in older patients with de novo acute myeloid leukemia: a randomized trial comparing mitoxantrone and intermediate-dose cytarabine with standard-dose cytarabine.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples